ATE445623T1 - 8a, 9-dihydro-4a-h-isothiazoloä5,4-bü chinolin-3, 4-dione und verwandte verbindungen als infektionsschutzmittel - Google Patents

8a, 9-dihydro-4a-h-isothiazoloä5,4-bü chinolin-3, 4-dione und verwandte verbindungen als infektionsschutzmittel

Info

Publication number
ATE445623T1
ATE445623T1 AT05857829T AT05857829T ATE445623T1 AT E445623 T1 ATE445623 T1 AT E445623T1 AT 05857829 T AT05857829 T AT 05857829T AT 05857829 T AT05857829 T AT 05857829T AT E445623 T1 ATE445623 T1 AT E445623T1
Authority
AT
Austria
Prior art keywords
sub
formula
compounds
provides
compositions
Prior art date
Application number
AT05857829T
Other languages
English (en)
Inventor
Barton Bradbury
Milind Deshpande
Michael Pucci
Qiuping Wang
Jason Wiles
Yongsheng Song
Akihiro Hashimoto
Edlaine Lucien
Original Assignee
Achillion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Achillion Pharmaceuticals Inc filed Critical Achillion Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE445623T1 publication Critical patent/ATE445623T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05857829T 2004-11-11 2005-11-10 8a, 9-dihydro-4a-h-isothiazoloä5,4-bü chinolin-3, 4-dione und verwandte verbindungen als infektionsschutzmittel ATE445623T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62696104P 2004-11-11 2004-11-11
PCT/US2005/040725 WO2006118605A2 (en) 2004-11-11 2005-11-10 8a, 9-dihydro-4a-h-isothiazolo[5,4-b] quinoline-3, 4-diones and related compounds as anti-infective agents

Publications (1)

Publication Number Publication Date
ATE445623T1 true ATE445623T1 (de) 2009-10-15

Family

ID=36980341

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05857829T ATE445623T1 (de) 2004-11-11 2005-11-10 8a, 9-dihydro-4a-h-isothiazoloä5,4-bü chinolin-3, 4-dione und verwandte verbindungen als infektionsschutzmittel

Country Status (12)

Country Link
US (1) US20060100215A1 (de)
EP (1) EP1809639B1 (de)
JP (1) JP2008519842A (de)
KR (1) KR20070085791A (de)
CN (1) CN101120004A (de)
AT (1) ATE445623T1 (de)
AU (1) AU2005331275A1 (de)
CA (1) CA2587485A1 (de)
DE (1) DE602005017178D1 (de)
IL (1) IL183153A0 (de)
MX (1) MX2007005731A (de)
WO (1) WO2006118605A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2616768C (en) * 2005-07-27 2014-05-06 Achillion Pharmaceuticals, Inc. 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
CA2695072A1 (en) * 2006-08-16 2008-02-21 Achillion Pharmaceuticals, Inc. Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767762A (en) * 1985-12-23 1988-08-30 Abbott Laboratories Tricyclic quinoline and naphthyride antibacterials
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
FR2645862B1 (fr) * 1989-04-18 1991-07-12 Esteve Labor Dr Derives d'isothiazolo-pyrydone azetidinyl substitues, leur preparation et leur application en tant que medicaments
US5071848A (en) * 1989-10-23 1991-12-10 Abbott Laboratories Tricyclic quinoline antineoplastic agents
US5580872A (en) * 1990-05-02 1996-12-03 Abbott Laboratories Quinolizinone type compounds
US5276041A (en) * 1991-11-08 1994-01-04 Kaken Pharmaceutical Co., Ltd. Oxime derivatives
NO304832B1 (no) * 1992-05-27 1999-02-22 Ube Industries Aminokinolonderivater samt middel mot HIV
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
WO2002048138A1 (en) * 2000-12-14 2002-06-20 The Procter & Gamble Company Antimicrobial quinolones
CN1867570A (zh) * 2003-08-12 2006-11-22 艾其林医药公司 作为抗感染试剂的异噻唑喹诺酮及其相关化合物

Also Published As

Publication number Publication date
DE602005017178D1 (de) 2009-11-26
EP1809639A2 (de) 2007-07-25
US20060100215A1 (en) 2006-05-11
KR20070085791A (ko) 2007-08-27
MX2007005731A (es) 2007-07-19
CA2587485A1 (en) 2006-11-09
WO2006118605A3 (en) 2006-12-21
EP1809639B1 (de) 2009-10-14
WO2006118605A2 (en) 2006-11-09
AU2005331275A1 (en) 2006-11-09
IL183153A0 (en) 2007-09-20
CN101120004A (zh) 2008-02-06
JP2008519842A (ja) 2008-06-12

Similar Documents

Publication Publication Date Title
DE602006017082D1 (de) 8-methoxy-9h-isothiazoloä5,4-büchinolin-3,4-dione und verwandte verbindungen als antiinfektive mittel
NO20060653L (no) Isotiazolokinoloner og beslektede forbindelser som anti-infektive midler
IL185164A0 (en) New isothiazoloquinolones and related compounds as anti-infective agents
WO2007023507A3 (en) Oxazolidinones bearing antimicrobial activity composition and methods of preparation
NO20071719L (no) Pyridylinhibitorer for "hedgehog"-signalisering
EA200601896A1 (ru) Производные пролина и их применение в качестве ингибиторов дипептидилпептидазы iv
ATE433447T1 (de) Pyrimiidinverbindungen
NO20083207L (no) Inhibitorer av IAP
ECSP066886A (es) Compuestos y métodos para el tratamiento de dislipidemia
BRPI0415602A (pt) composições estáveis de esporos, bactérias e/ou fungos
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren
WO2010115184A3 (en) Hydroxythienoquinolones and related compounds as anti-infective agents
WO2006120563A3 (en) Antibacterial agents
HK1159614A1 (en) Caspase inhibitors and uses thereof
DE602008004540D1 (de) 2-oxo-2-(2-phenyl-5,6,7,8-tetrahydroindolizin-3-yl)acetamidderivate und verwandte verbindungen als antipilzmittel
ATE543803T1 (de) 3-ä2-(3-azylamino-2-oxo-2h-pyridin-1- yl)acetylaminoü-4-oxopentansäurederivate und deren verwendung als caspase-inhibitoren
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
AP2003002942A0 (en) New derivatives of oxazolidinones as bacterial agents
ATE445623T1 (de) 8a, 9-dihydro-4a-h-isothiazoloä5,4-bü chinolin-3, 4-dione und verwandte verbindungen als infektionsschutzmittel
ATE339424T1 (de) 3-substituierte 7-alkylidene-3-cephem-4- carbonsäuren als beta-lactamase inhibitoren
ATE417052T1 (de) Oxazaborolidine als bakterielle effektoren
WO2008036420A3 (en) 9-(heteroaryl)-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
PT1175429E (pt) Derivados halo de 9-desoxo-9a-aza-9a-homoeritromicina a
WO2008038092A3 (en) Substituted piperidinophenyl oxazolidinones
BR0307468A (pt) Derivados tiadiazinona antimicrobianos úteis no tratamento de infecções bacterianas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties